Author |
Lopez-Medrano, F.
![]() Fernandez-Ruiz, M. ![]() Silva, J. T. ![]() Carver, P. L. ![]() van Delden, C. ![]() Merino, E. ![]() Perez-Saez, M. J. ![]() Montero, M. ![]() Coussement, J. ![]() de Abreu Mazzolin, M. ![]() ![]() Cervera, C. ![]() Santos, L. ![]() Sabe, N. ![]() Scemla, A. ![]() Cordero, E. ![]() Cruzado-Vega, L. ![]() Martin-Moreno, P. L. ![]() Len, O. ![]() Rudas, E. ![]() Ponce de Leon, A. ![]() Arriola, M. ![]() Lauzurica, R. ![]() David, M. D. ![]() Gonzalez-Rico, C. ![]() Henriquez-Palop, F. ![]() Fortun, J. ![]() Nucci, M. ![]() Manuel, O. ![]() Pano-Pardo, R. ![]() Montejo, M. ![]() Vena, A. ![]() Sanchez-Sobrino, B. ![]() Mazuecos, A. ![]() Pascual, J. ![]() Horcajada, J. P. ![]() Lecompte, T. ![]() Moreno, A. ![]() Carratala, J. ![]() Blanes, M. ![]() Hernandez, D. ![]() Hernandez-Mendez, E. A. ![]() Farinas, M. C. ![]() Perello-Carrascosa, M. ![]() Munoz, P. ![]() Andres, A. ![]() Aguado, J. M. ![]() |
Abstract | Objectives: To assess the risk factors for development of late-onset invasive pulmonary aspergillosis (IPA) after kidney transplantation (KT). Methods: We performed a multinational case-control study that retrospectively recruited 112 KT recipients diagnosed with IPA between 2000 and 2013. Controls were matched (1:1 ratio) by centre and date of transplantation. Immunosuppression-related events (IREs) included the occurrence of non-ventilator-associated pneumonia, tuberculosis, cytomegalovirus disease, and/or de novo malignancy. Results: We identified 61 cases of late (> 180 days after transplantation) IPA from 24 participating centres (accounting for 54.5% (61/112) of all cases included in the overall study). Most diagnoses (54.1% (33/61)) were established within the first 36 post-transplant months, although five cases occurred more than 10 years after transplantation. Overall mortality among cases was 47.5% (29/61). Compared with controls, cases were significantly older (p 0.010) and more likely to have pre-transplant chronic obstructive pulmonary disease (p 0.001) and a diagnosis of bloodstream infection (p 0.016) and IRE (p < 0.001) within the 6 months prior to the onset of late IPA. After multivariate adjustment, previous occurrence of IRE (OR 19.26 95% CI 2.07-179.46 p 0.009) was identified as an independent risk factor for late IPA. Conclusion: More than half of IPA cases after KT occur beyond the sixth month, with some of them presenting very late. Late IPA entails a poor prognosis. We identified some risk factors that could help the clinician to delimit the subgroup of KT recipients at the highest risk for late IPA. (c) 2017 European Society of Clinical Microbiology and Infectious Diseases. Published by Elsevier Ltd. All rights reserved. |
Keywords |
Case-control study
Kidney transplantation Late invasive pulmonary aspergillosis Risk factors |
xmlui.dri2xhtml.METS-1.0.item-coverage | Oxford |
Language | English |
Sponsor | Pfizer Gilead Sciences Astellas Pharma Merck Sharp Dohme Astellas Roche Lophius Bioscience Gilead Instituto de Salud Carlos III Novartis Plan Nacional de I+D+i and Instituto de Salud Carlos III (Proyecto Integrado de Excelencia (PIE) |Subdireccion General de Redes y Centros de Investigacion Cooperativa Spanish Ministry of Economy and Competitiveness Spanish Network for Research in Infectious Diseases European Development Regional Fund (EDRF) "A way to achieve Europe" Pfizer Pharmaceutical contract "Juan Rodes" from the Instituto de Salud Carlos III, Spanish Ministry of Economy and Competitiveness |
Grant number |
|
Date | 2018 |
Published in | Clinical Microbiology And Infection. Oxford, v. 24, n. 2, p. 192-198, 2018. |
ISSN | 1198-743X (Sherpa/Romeo, impact factor) |
Publisher | Elsevier Sci Ltd |
Extent | 192-198 |
Origin |
|
Access rights | Open access ![]() |
Type | Article |
Web of Science ID | WOS:000424846600019 |
URI | https://repositorio.unifesp.br/handle/11600/54200 |
File | Size | Format | View |
---|---|---|---|
There are no files associated with this item. |